Cargando…
A randomized, double-blind trial comparing the effect of two blood pressure targets on global brain metabolism after out-of-hospital cardiac arrest
PURPOSE: This study aimed to assess the effect of different blood pressure levels on global cerebral metabolism in comatose patients resuscitated from out-of-hospital cardiac arrest (OHCA). METHODS: In a double-blinded trial, we randomly assigned 60 comatose patients following OHCA to low (63 mmHg)...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951410/ https://www.ncbi.nlm.nih.gov/pubmed/36823636 http://dx.doi.org/10.1186/s13054-023-04376-y |
_version_ | 1784893384054276096 |
---|---|
author | Mølstrøm, Simon Nielsen, Troels Halfeld Nordstrøm, Carl-Henrik Forsse, Axel Møller, Søren Venø, Søren Mamaev, Dmitry Tencer, Tomas Theódórsdóttir, Ásta Krøigård, Thomas Møller, Jacob Hassager, Christian Kjærgaard, Jesper Schmidt, Henrik Toft, Palle |
author_facet | Mølstrøm, Simon Nielsen, Troels Halfeld Nordstrøm, Carl-Henrik Forsse, Axel Møller, Søren Venø, Søren Mamaev, Dmitry Tencer, Tomas Theódórsdóttir, Ásta Krøigård, Thomas Møller, Jacob Hassager, Christian Kjærgaard, Jesper Schmidt, Henrik Toft, Palle |
author_sort | Mølstrøm, Simon |
collection | PubMed |
description | PURPOSE: This study aimed to assess the effect of different blood pressure levels on global cerebral metabolism in comatose patients resuscitated from out-of-hospital cardiac arrest (OHCA). METHODS: In a double-blinded trial, we randomly assigned 60 comatose patients following OHCA to low (63 mmHg) or high (77 mmHg) mean arterial blood pressure (MAP). The trial was a sub-study in the Blood Pressure and Oxygenation Targets after Out-of-Hospital Cardiac Arrest-trial (BOX). Global cerebral metabolism utilizing jugular bulb microdialysis (JBM) and cerebral oxygenation (rSO(2)) was monitored continuously for 96 h. The lactate-to-pyruvate (LP) ratio is a marker of cellular redox status and increases during deficient oxygen delivery (ischemia, hypoxia) and mitochondrial dysfunction. The primary outcome was to compare time-averaged means of cerebral energy metabolites between MAP groups during post-resuscitation care. Secondary outcomes included metabolic patterns of cerebral ischemia, rSO(2), plasma neuron-specific enolase level at 48 h and neurological outcome at hospital discharge (cerebral performance category). RESULTS: We found a clear separation in MAP between the groups (15 mmHg, p < 0.001). Cerebral biochemical variables were not significantly different between MAP groups (LPR low MAP 19 (16–31) vs. high MAP 23 (16–33), p = 0.64). However, the LP ratio remained high (> 16) in both groups during the first 30 h. During the first 24 h, cerebral lactate > 2.5 mM, pyruvate levels > 110 µM, LP ratio > 30, and glycerol > 260 µM were highly predictive for poor neurological outcome and death with AUC 0.80. The median (IQR) rSO(2) during the first 48 h was 69.5% (62.0–75.0%) in the low MAP group and 69.0% (61.3–75.5%) in the high MAP group, p = 0.16. CONCLUSIONS: Among comatose patients resuscitated from OHCA, targeting a higher MAP 180 min after ROSC did not significantly improve cerebral energy metabolism within 96 h of post-resuscitation care. Patients with a poor clinical outcome exhibited significantly worse biochemical patterns, probably illustrating that insufficient tissue oxygenation and recirculation during the initial hours after ROSC were essential factors determining neurological outcome. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-023-04376-y. |
format | Online Article Text |
id | pubmed-9951410 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99514102023-02-25 A randomized, double-blind trial comparing the effect of two blood pressure targets on global brain metabolism after out-of-hospital cardiac arrest Mølstrøm, Simon Nielsen, Troels Halfeld Nordstrøm, Carl-Henrik Forsse, Axel Møller, Søren Venø, Søren Mamaev, Dmitry Tencer, Tomas Theódórsdóttir, Ásta Krøigård, Thomas Møller, Jacob Hassager, Christian Kjærgaard, Jesper Schmidt, Henrik Toft, Palle Crit Care Perspective PURPOSE: This study aimed to assess the effect of different blood pressure levels on global cerebral metabolism in comatose patients resuscitated from out-of-hospital cardiac arrest (OHCA). METHODS: In a double-blinded trial, we randomly assigned 60 comatose patients following OHCA to low (63 mmHg) or high (77 mmHg) mean arterial blood pressure (MAP). The trial was a sub-study in the Blood Pressure and Oxygenation Targets after Out-of-Hospital Cardiac Arrest-trial (BOX). Global cerebral metabolism utilizing jugular bulb microdialysis (JBM) and cerebral oxygenation (rSO(2)) was monitored continuously for 96 h. The lactate-to-pyruvate (LP) ratio is a marker of cellular redox status and increases during deficient oxygen delivery (ischemia, hypoxia) and mitochondrial dysfunction. The primary outcome was to compare time-averaged means of cerebral energy metabolites between MAP groups during post-resuscitation care. Secondary outcomes included metabolic patterns of cerebral ischemia, rSO(2), plasma neuron-specific enolase level at 48 h and neurological outcome at hospital discharge (cerebral performance category). RESULTS: We found a clear separation in MAP between the groups (15 mmHg, p < 0.001). Cerebral biochemical variables were not significantly different between MAP groups (LPR low MAP 19 (16–31) vs. high MAP 23 (16–33), p = 0.64). However, the LP ratio remained high (> 16) in both groups during the first 30 h. During the first 24 h, cerebral lactate > 2.5 mM, pyruvate levels > 110 µM, LP ratio > 30, and glycerol > 260 µM were highly predictive for poor neurological outcome and death with AUC 0.80. The median (IQR) rSO(2) during the first 48 h was 69.5% (62.0–75.0%) in the low MAP group and 69.0% (61.3–75.5%) in the high MAP group, p = 0.16. CONCLUSIONS: Among comatose patients resuscitated from OHCA, targeting a higher MAP 180 min after ROSC did not significantly improve cerebral energy metabolism within 96 h of post-resuscitation care. Patients with a poor clinical outcome exhibited significantly worse biochemical patterns, probably illustrating that insufficient tissue oxygenation and recirculation during the initial hours after ROSC were essential factors determining neurological outcome. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-023-04376-y. BioMed Central 2023-02-24 /pmc/articles/PMC9951410/ /pubmed/36823636 http://dx.doi.org/10.1186/s13054-023-04376-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Perspective Mølstrøm, Simon Nielsen, Troels Halfeld Nordstrøm, Carl-Henrik Forsse, Axel Møller, Søren Venø, Søren Mamaev, Dmitry Tencer, Tomas Theódórsdóttir, Ásta Krøigård, Thomas Møller, Jacob Hassager, Christian Kjærgaard, Jesper Schmidt, Henrik Toft, Palle A randomized, double-blind trial comparing the effect of two blood pressure targets on global brain metabolism after out-of-hospital cardiac arrest |
title | A randomized, double-blind trial comparing the effect of two blood pressure targets on global brain metabolism after out-of-hospital cardiac arrest |
title_full | A randomized, double-blind trial comparing the effect of two blood pressure targets on global brain metabolism after out-of-hospital cardiac arrest |
title_fullStr | A randomized, double-blind trial comparing the effect of two blood pressure targets on global brain metabolism after out-of-hospital cardiac arrest |
title_full_unstemmed | A randomized, double-blind trial comparing the effect of two blood pressure targets on global brain metabolism after out-of-hospital cardiac arrest |
title_short | A randomized, double-blind trial comparing the effect of two blood pressure targets on global brain metabolism after out-of-hospital cardiac arrest |
title_sort | randomized, double-blind trial comparing the effect of two blood pressure targets on global brain metabolism after out-of-hospital cardiac arrest |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951410/ https://www.ncbi.nlm.nih.gov/pubmed/36823636 http://dx.doi.org/10.1186/s13054-023-04376-y |
work_keys_str_mv | AT mølstrømsimon arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT nielsentroelshalfeld arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT nordstrømcarlhenrik arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT forsseaxel arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT møllersøren arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT venøsøren arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT mamaevdmitry arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT tencertomas arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT theodorsdottirasta arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT krøigardthomas arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT møllerjacob arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT hassagerchristian arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT kjærgaardjesper arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT schmidthenrik arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT toftpalle arandomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT mølstrømsimon randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT nielsentroelshalfeld randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT nordstrømcarlhenrik randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT forsseaxel randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT møllersøren randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT venøsøren randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT mamaevdmitry randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT tencertomas randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT theodorsdottirasta randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT krøigardthomas randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT møllerjacob randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT hassagerchristian randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT kjærgaardjesper randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT schmidthenrik randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest AT toftpalle randomizeddoubleblindtrialcomparingtheeffectoftwobloodpressuretargetsonglobalbrainmetabolismafteroutofhospitalcardiacarrest |